However, the NKG2D pathway plays a complex role in tumor immunity, with some evidence it can also mediate the opposing effect of downmodulating NK cell tumor immunity or even promoting HCC progression (8, 9). This evidence concerns the gene KLRK1 and hepatocellular carcinoma.